LB PHARMACEUTICALS INC
LBRX·50180M108·US·Common Stock·Healthcare - Biotechnology-Activist
LBRX (LB PHARMACEUTICALS INC) is held by 50 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($60.9M), RA CAPITAL MANAGEMENT, L.P. ($54.5M), JPMORGAN CHASE & CO ($33.2M). Net institutional sentiment: Bullish.
50
Holders
Avg rating(10 Elite)
$320.3M
Total Value
69% (55)
Fund Consensus
34 buying - 15 selling
Who's Trading
ActivistCACaligan Partners LP5.0%May 15, 2026
ActivistTCTCG Crossover GP II, LLC6.4%May 15, 2026
ActivistDTDeep Track Biotechnology Master Fund, Ltd.9.4%Feb 10, 2026
ActivistBPBlackRock Portfolio Management LLC3.8%Jan 21, 2026
InsiderDLDeep Track Biotechnology Master Fund, Ltd.Buy $30.0MSep 12, 2025
InsiderNRNussbaum RanBuy $15.0MSep 12, 2025
InsiderPLPontifax Management 4 G.P. (2015) Ltd.Buy $15.0MSep 12, 2025
InsiderVLVida Ventures GP III, L.L.C.Buy $5.0MSep 12, 2025
13F: Insider & Congress:
Showing 1-20 of 55
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer